| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lead | 64 | 2024 | 879 | 11.250 |
Why?
|
| Amyotrophic Lateral Sclerosis | 42 | 2024 | 1469 | 8.500 |
Why?
|
| Environmental Exposure | 77 | 2024 | 4486 | 5.370 |
Why?
|
| Football | 23 | 2024 | 503 | 4.620 |
Why?
|
| Occupational Exposure | 22 | 2022 | 1813 | 4.220 |
Why?
|
| Nails | 12 | 2024 | 296 | 4.040 |
Why?
|
| Spectrometry, X-Ray Emission | 21 | 2024 | 143 | 3.670 |
Why?
|
| Prenatal Exposure Delayed Effects | 19 | 2024 | 2518 | 3.500 |
Why?
|
| Bone and Bones | 33 | 2024 | 2568 | 3.430 |
Why?
|
| Maternal Exposure | 18 | 2024 | 1067 | 3.200 |
Why?
|
| Air Pollutants | 29 | 2024 | 2896 | 2.640 |
Why?
|
| Air Pollution | 27 | 2024 | 2359 | 2.630 |
Why?
|
| Environmental Pollutants | 22 | 2024 | 1277 | 2.500 |
Why?
|
| Cognition Disorders | 19 | 2020 | 3979 | 2.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 11 | 2024 | 3708 | 1.950 |
Why?
|
| Parkinson Disease | 23 | 2021 | 2877 | 1.890 |
Why?
|
| Brain Concussion | 12 | 2024 | 1404 | 1.870 |
Why?
|
| Lead Poisoning | 11 | 2024 | 322 | 1.800 |
Why?
|
| Denmark | 16 | 2023 | 771 | 1.800 |
Why?
|
| Cognition | 26 | 2024 | 6990 | 1.730 |
Why?
|
| Persian Gulf Syndrome | 2 | 2022 | 47 | 1.580 |
Why?
|
| Anxiety | 9 | 2024 | 4573 | 1.540 |
Why?
|
| Manganese | 8 | 2022 | 395 | 1.500 |
Why?
|
| Child Abuse | 5 | 2020 | 1077 | 1.500 |
Why?
|
| Depression | 15 | 2024 | 8124 | 1.430 |
Why?
|
| Metals | 7 | 2024 | 719 | 1.410 |
Why?
|
| Particulate Matter | 25 | 2024 | 2605 | 1.400 |
Why?
|
| Live Birth | 4 | 2023 | 511 | 1.290 |
Why?
|
| Adult Survivors of Child Abuse | 3 | 2020 | 294 | 1.290 |
Why?
|
| Mercury | 4 | 2021 | 290 | 1.260 |
Why?
|
| Pesticides | 6 | 2020 | 296 | 1.230 |
Why?
|
| Patella | 15 | 2019 | 315 | 1.210 |
Why?
|
| Welding | 6 | 2017 | 89 | 1.180 |
Why?
|
| Tibia | 18 | 2020 | 1070 | 1.160 |
Why?
|
| Environmental Monitoring | 12 | 2024 | 1460 | 1.150 |
Why?
|
| Aging | 28 | 2024 | 8708 | 1.140 |
Why?
|
| Mothers | 7 | 2022 | 2198 | 1.120 |
Why?
|
| Formaldehyde | 3 | 2020 | 358 | 1.110 |
Why?
|
| Nitrogen Dioxide | 9 | 2023 | 522 | 1.110 |
Why?
|
| Metals, Heavy | 6 | 2024 | 148 | 1.100 |
Why?
|
| X-Rays | 7 | 2024 | 307 | 1.090 |
Why?
|
| Polychlorinated Biphenyls | 5 | 2022 | 236 | 1.090 |
Why?
|
| Smoking | 18 | 2024 | 9053 | 1.070 |
Why?
|
| Humans | 296 | 2024 | 761504 | 1.070 |
Why?
|
| Arsenic | 9 | 2024 | 362 | 1.030 |
Why?
|
| Athletes | 10 | 2024 | 1137 | 1.020 |
Why?
|
| Pregnancy | 47 | 2024 | 29874 | 1.000 |
Why?
|
| Occupational Diseases | 5 | 2020 | 1490 | 0.980 |
Why?
|
| Aged | 138 | 2024 | 169289 | 0.960 |
Why?
|
| Autistic Disorder | 5 | 2022 | 1220 | 0.960 |
Why?
|
| Dementia | 4 | 2023 | 2686 | 0.950 |
Why?
|
| Veterans | 8 | 2022 | 2647 | 0.950 |
Why?
|
| Iron | 4 | 2024 | 1793 | 0.950 |
Why?
|
| Male | 188 | 2024 | 360804 | 0.940 |
Why?
|
| Lead Poisoning, Nervous System | 2 | 2014 | 12 | 0.910 |
Why?
|
| Case-Control Studies | 31 | 2024 | 22176 | 0.910 |
Why?
|
| Middle Aged | 137 | 2024 | 220895 | 0.900 |
Why?
|
| Risk Factors | 66 | 2024 | 74206 | 0.880 |
Why?
|
| Female | 162 | 2024 | 392644 | 0.860 |
Why?
|
| Military Personnel | 4 | 2017 | 1246 | 0.860 |
Why?
|
| Israel | 11 | 2024 | 726 | 0.830 |
Why?
|
| Child Development Disorders, Pervasive | 4 | 2015 | 600 | 0.810 |
Why?
|
| Vehicle Emissions | 6 | 2022 | 656 | 0.810 |
Why?
|
| Adult | 122 | 2024 | 221177 | 0.810 |
Why?
|
| Odds Ratio | 18 | 2021 | 9646 | 0.810 |
Why?
|
| Cohort Studies | 53 | 2024 | 41487 | 0.790 |
Why?
|
| Athletic Injuries | 4 | 2024 | 1216 | 0.780 |
Why?
|
| Lead Poisoning, Nervous System, Adult | 3 | 2013 | 12 | 0.780 |
Why?
|
| Diethylstilbestrol | 2 | 2018 | 87 | 0.770 |
Why?
|
| Selenium | 2 | 2024 | 417 | 0.770 |
Why?
|
| Hazardous Substances | 3 | 2012 | 153 | 0.750 |
Why?
|
| Craniocerebral Trauma | 2 | 2016 | 490 | 0.750 |
Why?
|
| Chromium | 2 | 2020 | 132 | 0.730 |
Why?
|
| Air Pollutants, Occupational | 4 | 2017 | 407 | 0.720 |
Why?
|
| Food Contamination | 4 | 2019 | 191 | 0.700 |
Why?
|
| Nickel | 1 | 2020 | 128 | 0.690 |
Why?
|
| Glutathione S-Transferase pi | 3 | 2015 | 99 | 0.680 |
Why?
|
| Neuropsychological Tests | 19 | 2023 | 7045 | 0.670 |
Why?
|
| Pregnancy Complications | 4 | 2020 | 2947 | 0.660 |
Why?
|
| Registries | 10 | 2021 | 8224 | 0.650 |
Why?
|
| United States | 67 | 2024 | 72334 | 0.640 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2019 | 370 | 0.640 |
Why?
|
| Acetaminophen | 3 | 2022 | 554 | 0.640 |
Why?
|
| Solvents | 1 | 2020 | 295 | 0.640 |
Why?
|
| Aged, 80 and over | 62 | 2024 | 58976 | 0.630 |
Why?
|
| Water Pollutants, Chemical | 3 | 2024 | 359 | 0.620 |
Why?
|
| Baseball | 1 | 2019 | 95 | 0.600 |
Why?
|
| Logistic Models | 17 | 2019 | 13255 | 0.600 |
Why?
|
| Abortion, Spontaneous | 2 | 2023 | 533 | 0.600 |
Why?
|
| Occupations | 2 | 2014 | 515 | 0.600 |
Why?
|
| Death Certificates | 4 | 2015 | 167 | 0.590 |
Why?
|
| Epidemiologic Methods | 3 | 2018 | 1336 | 0.580 |
Why?
|
| Polymorphism, Genetic | 8 | 2019 | 4243 | 0.580 |
Why?
|
| Hypospadias | 1 | 2018 | 97 | 0.580 |
Why?
|
| DNA Methylation | 11 | 2021 | 4398 | 0.580 |
Why?
|
| Cryptorchidism | 1 | 2018 | 151 | 0.570 |
Why?
|
| Birds | 1 | 2017 | 168 | 0.560 |
Why?
|
| Prospective Studies | 42 | 2024 | 54425 | 0.550 |
Why?
|
| Fluorescence | 4 | 2021 | 756 | 0.550 |
Why?
|
| Child | 41 | 2024 | 80153 | 0.530 |
Why?
|
| Fertility | 1 | 2021 | 771 | 0.530 |
Why?
|
| Androgens | 2 | 2021 | 1286 | 0.530 |
Why?
|
| Mass Spectrometry | 3 | 2024 | 2192 | 0.520 |
Why?
|
| Longitudinal Studies | 22 | 2023 | 14605 | 0.520 |
Why?
|
| Phobic Disorders | 2 | 2012 | 439 | 0.510 |
Why?
|
| Insecticides | 3 | 2013 | 191 | 0.510 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2017 | 273 | 0.500 |
Why?
|
| Hydrocarbons, Chlorinated | 2 | 2021 | 121 | 0.500 |
Why?
|
| Metabolic Diseases | 2 | 2021 | 683 | 0.490 |
Why?
|
| Soot | 5 | 2019 | 221 | 0.490 |
Why?
|
| Hypothyroidism | 1 | 2020 | 668 | 0.490 |
Why?
|
| Endocrine Disruptors | 1 | 2018 | 264 | 0.490 |
Why?
|
| Proportional Hazards Models | 14 | 2022 | 12463 | 0.480 |
Why?
|
| Spouses | 1 | 2017 | 283 | 0.480 |
Why?
|
| Mental Health | 5 | 2023 | 3250 | 0.480 |
Why?
|
| Language | 1 | 2024 | 1540 | 0.470 |
Why?
|
| Nutrition Surveys | 7 | 2018 | 1733 | 0.470 |
Why?
|
| Observation | 1 | 2016 | 310 | 0.460 |
Why?
|
| Socioeconomic Factors | 10 | 2019 | 7827 | 0.460 |
Why?
|
| Dentin | 2 | 2024 | 75 | 0.460 |
Why?
|
| Incidence | 20 | 2022 | 21353 | 0.460 |
Why?
|
| Sexual Behavior | 1 | 2024 | 2180 | 0.450 |
Why?
|
| Tooth, Deciduous | 2 | 2024 | 76 | 0.450 |
Why?
|
| Cardiovascular Diseases | 13 | 2024 | 15500 | 0.450 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 2 | 2005 | 86 | 0.450 |
Why?
|
| Tremor | 1 | 2015 | 191 | 0.450 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2013 | 28 | 0.440 |
Why?
|
| Oxidative Stress | 7 | 2019 | 3113 | 0.430 |
Why?
|
| Premature Birth | 2 | 2024 | 1782 | 0.410 |
Why?
|
| Olfaction Disorders | 1 | 2015 | 224 | 0.410 |
Why?
|
| Glutathione Transferase | 2 | 2019 | 565 | 0.410 |
Why?
|
| Neurodegenerative Diseases | 4 | 2023 | 1087 | 0.400 |
Why?
|
| Linear Models | 9 | 2019 | 5871 | 0.400 |
Why?
|
| Fluorocarbons | 3 | 2012 | 492 | 0.400 |
Why?
|
| Spinal Dysraphism | 2 | 2024 | 178 | 0.400 |
Why?
|
| Ozone | 3 | 2023 | 483 | 0.400 |
Why?
|
| Population Surveillance | 6 | 2020 | 2598 | 0.390 |
Why?
|
| Agriculture | 1 | 2013 | 191 | 0.390 |
Why?
|
| Health Status Disparities | 2 | 2020 | 1852 | 0.390 |
Why?
|
| Cross-Sectional Studies | 23 | 2024 | 26125 | 0.390 |
Why?
|
| Protective Agents | 1 | 2012 | 150 | 0.380 |
Why?
|
| Folic Acid | 4 | 2024 | 1323 | 0.370 |
Why?
|
| Sex Offenses | 1 | 2015 | 352 | 0.370 |
Why?
|
| Ammonia | 2 | 2003 | 237 | 0.370 |
Why?
|
| Crime Victims | 1 | 2015 | 347 | 0.360 |
Why?
|
| Birth Weight | 6 | 2023 | 2103 | 0.360 |
Why?
|
| Body Weight | 1 | 2021 | 4618 | 0.360 |
Why?
|
| Mortality | 2 | 2019 | 2901 | 0.350 |
Why?
|
| Accidents, Occupational | 2 | 2003 | 249 | 0.350 |
Why?
|
| Uric Acid | 3 | 2018 | 807 | 0.340 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3245 | 0.330 |
Why?
|
| Vitamin E | 4 | 2024 | 872 | 0.330 |
Why?
|
| Copper | 2 | 2024 | 369 | 0.330 |
Why?
|
| Suicide | 1 | 2020 | 1601 | 0.330 |
Why?
|
| Young Adult | 38 | 2024 | 59243 | 0.330 |
Why?
|
| Walking | 3 | 2013 | 1198 | 0.320 |
Why?
|
| Quality of Life | 7 | 2022 | 13367 | 0.320 |
Why?
|
| Aspartic Acid | 3 | 2007 | 576 | 0.310 |
Why?
|
| MicroRNAs | 5 | 2024 | 3816 | 0.310 |
Why?
|
| Volatile Organic Compounds | 2 | 2020 | 86 | 0.310 |
Why?
|
| Bayes Theorem | 8 | 2024 | 2330 | 0.310 |
Why?
|
| Environmental Pollution | 1 | 2009 | 124 | 0.300 |
Why?
|
| Child, Preschool | 19 | 2024 | 42230 | 0.300 |
Why?
|
| Fear | 2 | 2015 | 1476 | 0.290 |
Why?
|
| Nigeria | 3 | 2019 | 770 | 0.290 |
Why?
|
| California | 2 | 2024 | 1429 | 0.290 |
Why?
|
| Infant, Newborn | 18 | 2024 | 26198 | 0.290 |
Why?
|
| Review Literature as Topic | 1 | 2009 | 348 | 0.290 |
Why?
|
| Hypertension | 7 | 2024 | 8540 | 0.290 |
Why?
|
| Electrocardiography | 3 | 2017 | 6377 | 0.280 |
Why?
|
| Solar Activity | 2 | 2024 | 44 | 0.280 |
Why?
|
| Causality | 3 | 2024 | 1242 | 0.280 |
Why?
|
| Boston | 12 | 2024 | 9326 | 0.280 |
Why?
|
| Diabetes, Gestational | 4 | 2021 | 1248 | 0.270 |
Why?
|
| Depressive Disorder | 2 | 2016 | 3728 | 0.270 |
Why?
|
| Sex Ratio | 2 | 2006 | 108 | 0.270 |
Why?
|
| Self Report | 6 | 2021 | 3724 | 0.270 |
Why?
|
| Cause of Death | 4 | 2019 | 3683 | 0.270 |
Why?
|
| Panic Disorder | 1 | 2009 | 613 | 0.270 |
Why?
|
| Hot Temperature | 2 | 2023 | 1440 | 0.260 |
Why?
|
| Motor Activity | 2 | 2013 | 2715 | 0.250 |
Why?
|
| Anxiety Disorders | 2 | 2023 | 2720 | 0.250 |
Why?
|
| Central Nervous System | 1 | 2013 | 1336 | 0.250 |
Why?
|
| Health Surveys | 8 | 2019 | 4061 | 0.250 |
Why?
|
| Radiography | 6 | 2023 | 6965 | 0.240 |
Why?
|
| Aryldialkylphosphatase | 2 | 2022 | 64 | 0.240 |
Why?
|
| Risk | 10 | 2016 | 9610 | 0.240 |
Why?
|
| Blood Chemical Analysis | 1 | 2006 | 437 | 0.240 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2024 | 15936 | 0.240 |
Why?
|
| Prevalence | 11 | 2024 | 15732 | 0.240 |
Why?
|
| Seasons | 2 | 2018 | 1520 | 0.230 |
Why?
|
| Dental Cementum | 1 | 2024 | 53 | 0.230 |
Why?
|
| Gestational Age | 4 | 2023 | 3577 | 0.230 |
Why?
|
| Seafood | 2 | 2019 | 393 | 0.230 |
Why?
|
| Paternal Exposure | 2 | 2024 | 96 | 0.230 |
Why?
|
| Heat Stress Disorders | 2 | 2002 | 80 | 0.230 |
Why?
|
| Mental Status Schedule | 2 | 2015 | 314 | 0.220 |
Why?
|
| Health Status | 7 | 2024 | 4077 | 0.220 |
Why?
|
| Weather | 2 | 2002 | 231 | 0.220 |
Why?
|
| Diet | 9 | 2024 | 8075 | 0.220 |
Why?
|
| Massachusetts | 10 | 2024 | 8830 | 0.220 |
Why?
|
| Age Factors | 15 | 2024 | 18395 | 0.220 |
Why?
|
| Adolescent | 26 | 2022 | 88319 | 0.220 |
Why?
|
| Depressive Disorder, Major | 3 | 2024 | 4761 | 0.220 |
Why?
|
| Age of Onset | 3 | 2017 | 3305 | 0.220 |
Why?
|
| Fish Products | 1 | 2003 | 30 | 0.220 |
Why?
|
| Fetal Development | 3 | 2023 | 769 | 0.220 |
Why?
|
| Cadmium | 2 | 2018 | 214 | 0.210 |
Why?
|
| Spinal Osteophytosis | 1 | 2003 | 30 | 0.210 |
Why?
|
| Myelography | 1 | 2003 | 72 | 0.210 |
Why?
|
| Strontium | 1 | 2022 | 21 | 0.210 |
Why?
|
| Military Medicine | 1 | 2005 | 184 | 0.210 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2021 | 731 | 0.210 |
Why?
|
| Caprylates | 3 | 2012 | 115 | 0.210 |
Why?
|
| Gulf War | 1 | 2022 | 33 | 0.210 |
Why?
|
| Tooth | 1 | 2024 | 210 | 0.200 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 1881 | 0.200 |
Why?
|
| Risk Assessment | 10 | 2021 | 23995 | 0.200 |
Why?
|
| Arsenicals | 2 | 2019 | 118 | 0.200 |
Why?
|
| Limit of Detection | 3 | 2017 | 273 | 0.200 |
Why?
|
| Environment | 1 | 2008 | 1123 | 0.200 |
Why?
|
| Frozen Sections | 1 | 2003 | 153 | 0.200 |
Why?
|
| Patient Discharge | 1 | 2015 | 3443 | 0.200 |
Why?
|
| Autonomic Nervous System | 2 | 2017 | 703 | 0.200 |
Why?
|
| Fishes | 1 | 2005 | 603 | 0.190 |
Why?
|
| Bangladesh | 5 | 2024 | 736 | 0.190 |
Why?
|
| Bone Substitutes | 1 | 2003 | 236 | 0.190 |
Why?
|
| Dioxins | 1 | 2022 | 91 | 0.190 |
Why?
|
| Epigenesis, Genetic | 3 | 2021 | 3802 | 0.190 |
Why?
|
| Blood Pressure | 3 | 2015 | 8481 | 0.190 |
Why?
|
| Particle Size | 4 | 2022 | 1648 | 0.190 |
Why?
|
| Cooperative Behavior | 1 | 2008 | 1505 | 0.190 |
Why?
|
| Follow-Up Studies | 17 | 2021 | 39106 | 0.190 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 2244 | 0.190 |
Why?
|
| Age Distribution | 4 | 2014 | 2880 | 0.180 |
Why?
|
| Methylene Chloride | 1 | 2020 | 11 | 0.180 |
Why?
|
| Chronic Disease | 4 | 2022 | 9318 | 0.180 |
Why?
|
| Retrospective Studies | 17 | 2024 | 80636 | 0.170 |
Why?
|
| Employment | 2 | 2017 | 1118 | 0.170 |
Why?
|
| Mexico | 2 | 2020 | 764 | 0.170 |
Why?
|
| Congenital Abnormalities | 1 | 2024 | 709 | 0.170 |
Why?
|
| Creatine | 3 | 2007 | 427 | 0.170 |
Why?
|
| Valine | 2 | 2013 | 408 | 0.170 |
Why?
|
| Urban Health | 1 | 2002 | 532 | 0.170 |
Why?
|
| Potassium, Dietary | 1 | 2019 | 103 | 0.170 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 2019 | 27 | 0.170 |
Why?
|
| Carbon | 3 | 2022 | 666 | 0.160 |
Why?
|
| Back Pain | 1 | 2003 | 545 | 0.160 |
Why?
|
| Menstrual Hygiene Products | 1 | 2019 | 20 | 0.160 |
Why?
|
| Sensory Gating | 1 | 2019 | 47 | 0.160 |
Why?
|
| Mental Disorders | 5 | 2024 | 6845 | 0.160 |
Why?
|
| Wounds and Injuries | 5 | 2013 | 2491 | 0.160 |
Why?
|
| Thyroid Hormones | 1 | 2022 | 404 | 0.160 |
Why?
|
| Apolipoproteins E | 2 | 2015 | 1444 | 0.160 |
Why?
|
| Meconium | 1 | 2019 | 47 | 0.160 |
Why?
|
| Reproducibility of Results | 6 | 2021 | 20098 | 0.160 |
Why?
|
| Nurses | 4 | 2016 | 2478 | 0.160 |
Why?
|
| Genotype | 6 | 2015 | 12990 | 0.150 |
Why?
|
| Reproduction | 1 | 2003 | 645 | 0.150 |
Why?
|
| Public Health | 2 | 2020 | 2669 | 0.150 |
Why?
|
| Coronary Vasospasm | 1 | 2018 | 81 | 0.150 |
Why?
|
| Tobacco, Smokeless | 1 | 2019 | 133 | 0.150 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2018 | 52 | 0.150 |
Why?
|
| Thyroxine | 1 | 2022 | 666 | 0.150 |
Why?
|
| Trace Elements | 1 | 2019 | 195 | 0.150 |
Why?
|
| Pregnancy Outcome | 2 | 2019 | 2921 | 0.150 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2018 | 57 | 0.150 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2023 | 975 | 0.150 |
Why?
|
| Thinness | 1 | 2021 | 490 | 0.150 |
Why?
|
| Brain Injuries | 1 | 2009 | 2053 | 0.150 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2012 | 1722 | 0.150 |
Why?
|
| Pregnancy Trimesters | 1 | 2018 | 197 | 0.150 |
Why?
|
| Time Factors | 8 | 2024 | 39967 | 0.140 |
Why?
|
| Memory, Short-Term | 3 | 2022 | 982 | 0.140 |
Why?
|
| Fathers | 2 | 2024 | 376 | 0.140 |
Why?
|
| Epidemiologic Studies | 1 | 2020 | 675 | 0.140 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2015 | 4575 | 0.140 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 66 | 0.140 |
Why?
|
| United States Department of Veterans Affairs | 7 | 2019 | 928 | 0.140 |
Why?
|
| Body Mass Index | 5 | 2023 | 12953 | 0.140 |
Why?
|
| Infant | 12 | 2024 | 36192 | 0.140 |
Why?
|
| Phantoms, Imaging | 2 | 2019 | 2526 | 0.140 |
Why?
|
| Veterans Health | 1 | 2018 | 215 | 0.140 |
Why?
|
| Mouth Mucosa | 1 | 2019 | 432 | 0.140 |
Why?
|
| Post-Concussion Syndrome | 1 | 2019 | 243 | 0.140 |
Why?
|
| Spinal Fractures | 1 | 2003 | 705 | 0.140 |
Why?
|
| Women's Health | 2 | 2017 | 2065 | 0.130 |
Why?
|
| Metformin | 1 | 2024 | 906 | 0.130 |
Why?
|
| Erectile Dysfunction | 1 | 2019 | 444 | 0.130 |
Why?
|
| Infant, Low Birth Weight | 1 | 2021 | 870 | 0.130 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 461 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2024 | 1376 | 0.130 |
Why?
|
| Sodium, Dietary | 1 | 2019 | 425 | 0.130 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 5840 | 0.130 |
Why?
|
| Calibration | 1 | 2018 | 818 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2021 | 5247 | 0.130 |
Why?
|
| Obesity | 2 | 2015 | 12947 | 0.130 |
Why?
|
| Community Health Planning | 1 | 2016 | 164 | 0.130 |
Why?
|
| France | 2 | 2015 | 497 | 0.130 |
Why?
|
| Sexuality | 1 | 2017 | 180 | 0.130 |
Why?
|
| Antioxidants | 3 | 2016 | 1668 | 0.130 |
Why?
|
| Sulfonic Acids | 2 | 2012 | 103 | 0.120 |
Why?
|
| Monte Carlo Method | 2 | 2019 | 1258 | 0.120 |
Why?
|
| World War II | 1 | 2015 | 61 | 0.120 |
Why?
|
| Thyroid Gland | 1 | 2022 | 1168 | 0.120 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2013 | 1349 | 0.120 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2014 | 82 | 0.120 |
Why?
|
| Body Burden | 2 | 2013 | 158 | 0.120 |
Why?
|
| Regression Analysis | 5 | 2014 | 6343 | 0.120 |
Why?
|
| Body Height | 1 | 2021 | 1570 | 0.120 |
Why?
|
| Menopause | 2 | 2014 | 1646 | 0.120 |
Why?
|
| Hypoglycemic Agents | 2 | 2024 | 3085 | 0.120 |
Why?
|
| Ascorbic Acid | 2 | 2016 | 655 | 0.120 |
Why?
|
| Wisconsin | 4 | 2002 | 122 | 0.120 |
Why?
|
| Learning | 2 | 2015 | 1740 | 0.120 |
Why?
|
| Computer Simulation | 3 | 2023 | 6240 | 0.120 |
Why?
|
| Cadaver | 1 | 2019 | 1358 | 0.120 |
Why?
|
| Great Lakes Region | 2 | 2005 | 3 | 0.120 |
Why?
|
| Perfume | 1 | 2014 | 9 | 0.120 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2014 | 23 | 0.120 |
Why?
|
| Disability Evaluation | 2 | 2012 | 1835 | 0.120 |
Why?
|
| Nitrobenzenes | 1 | 2014 | 66 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2015 | 6019 | 0.120 |
Why?
|
| Physical Examination | 1 | 2020 | 1255 | 0.110 |
Why?
|
| New Hampshire | 2 | 2024 | 175 | 0.110 |
Why?
|
| Demography | 1 | 2019 | 1648 | 0.110 |
Why?
|
| Euglena gracilis | 1 | 2013 | 3 | 0.110 |
Why?
|
| Hippocampus | 1 | 2007 | 3766 | 0.110 |
Why?
|
| Methylmercury Compounds | 1 | 2014 | 103 | 0.110 |
Why?
|
| Heart | 2 | 2017 | 4404 | 0.110 |
Why?
|
| Siblings | 1 | 2018 | 825 | 0.110 |
Why?
|
| Fungicides, Industrial | 1 | 2013 | 13 | 0.110 |
Why?
|
| Twins, Monozygotic | 2 | 2007 | 470 | 0.110 |
Why?
|
| Dairy Products | 1 | 2017 | 490 | 0.110 |
Why?
|
| Disease Progression | 1 | 2011 | 13506 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2003 | 1286 | 0.110 |
Why?
|
| Schizophrenia | 2 | 2024 | 6937 | 0.110 |
Why?
|
| Executive Function | 1 | 2022 | 1389 | 0.110 |
Why?
|
| Radiometry | 1 | 2019 | 813 | 0.110 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1999 | 894 | 0.110 |
Why?
|
| Osteoporosis | 1 | 2003 | 1606 | 0.110 |
Why?
|
| Transferrin | 1 | 2014 | 283 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2020 | 2707 | 0.110 |
Why?
|
| Carotenoids | 1 | 2016 | 621 | 0.110 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2018 | 497 | 0.110 |
Why?
|
| Handwriting | 1 | 2013 | 26 | 0.110 |
Why?
|
| Social Behavior | 2 | 2023 | 1135 | 0.110 |
Why?
|
| Pain | 3 | 2024 | 5073 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 2003 | 1879 | 0.110 |
Why?
|
| Multivariate Analysis | 4 | 2019 | 12059 | 0.110 |
Why?
|
| Hemochromatosis | 1 | 2014 | 174 | 0.110 |
Why?
|
| Comorbidity | 5 | 2021 | 10508 | 0.110 |
Why?
|
| Coronary Disease | 2 | 2018 | 5914 | 0.110 |
Why?
|
| Trail Making Test | 1 | 2012 | 57 | 0.100 |
Why?
|
| Attention | 2 | 2015 | 2396 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 12148 | 0.100 |
Why?
|
| Intraocular Pressure | 1 | 2019 | 1294 | 0.100 |
Why?
|
| Alkanesulfonic Acids | 2 | 2012 | 201 | 0.100 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 836 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 15842 | 0.100 |
Why?
|
| Herbicides | 1 | 2013 | 105 | 0.100 |
Why?
|
| Parents | 2 | 2023 | 3563 | 0.100 |
Why?
|
| Occupational Health | 1 | 2019 | 806 | 0.100 |
Why?
|
| Weightlessness | 1 | 2013 | 102 | 0.100 |
Why?
|
| China | 4 | 2022 | 2369 | 0.100 |
Why?
|
| Electronic Health Records | 2 | 2022 | 4811 | 0.100 |
Why?
|
| Receptors, Calcitriol | 1 | 2015 | 360 | 0.100 |
Why?
|
| Alu Elements | 1 | 2012 | 115 | 0.100 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 1560 | 0.100 |
Why?
|
| Caffeine | 2 | 2022 | 700 | 0.100 |
Why?
|
| Vitamin B Complex | 1 | 2014 | 299 | 0.100 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 702 | 0.100 |
Why?
|
| Apolipoprotein E4 | 1 | 2016 | 708 | 0.100 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2018 | 738 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2007 | 3769 | 0.100 |
Why?
|
| Neoplasms | 5 | 2018 | 22170 | 0.100 |
Why?
|
| Glucose | 2 | 2021 | 4346 | 0.090 |
Why?
|
| Verbal Behavior | 1 | 2012 | 335 | 0.090 |
Why?
|
| Vitamin E Deficiency | 1 | 2011 | 30 | 0.090 |
Why?
|
| Pilot Projects | 4 | 2022 | 8631 | 0.090 |
Why?
|
| Epidemiologic Research Design | 2 | 2012 | 368 | 0.090 |
Why?
|
| Child Abuse, Sexual | 1 | 2014 | 403 | 0.090 |
Why?
|
| Homocysteine | 1 | 2014 | 638 | 0.090 |
Why?
|
| Air Pollution, Indoor | 1 | 2018 | 901 | 0.090 |
Why?
|
| Confidence Intervals | 4 | 2011 | 2927 | 0.090 |
Why?
|
| Amygdala | 1 | 1999 | 1354 | 0.090 |
Why?
|
| Space Flight | 1 | 2013 | 215 | 0.090 |
Why?
|
| Dieldrin | 1 | 2010 | 7 | 0.090 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2012 | 330 | 0.090 |
Why?
|
| Alleles | 2 | 2019 | 6863 | 0.090 |
Why?
|
| Eating | 1 | 2017 | 1539 | 0.090 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 368 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2020 | 2093 | 0.090 |
Why?
|
| Heart Rate | 3 | 2017 | 4195 | 0.090 |
Why?
|
| Overweight | 1 | 2021 | 2417 | 0.090 |
Why?
|
| Telomere | 1 | 2016 | 943 | 0.090 |
Why?
|
| Filtration | 1 | 2010 | 228 | 0.080 |
Why?
|
| Cholesterol | 2 | 2016 | 2904 | 0.080 |
Why?
|
| Medical Records | 1 | 2015 | 1408 | 0.080 |
Why?
|
| Heart Block | 1 | 2011 | 386 | 0.080 |
Why?
|
| Water Supply | 1 | 2010 | 204 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 2 | 2014 | 2691 | 0.080 |
Why?
|
| Telephone | 1 | 2012 | 627 | 0.080 |
Why?
|
| Porphobilinogen Synthase | 1 | 2008 | 27 | 0.080 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 865 | 0.080 |
Why?
|
| Amlodipine | 1 | 2009 | 84 | 0.080 |
Why?
|
| Testosterone | 1 | 2019 | 2472 | 0.080 |
Why?
|
| Awareness | 1 | 2013 | 648 | 0.080 |
Why?
|
| Auditory Threshold | 1 | 2010 | 369 | 0.080 |
Why?
|
| Finland | 1 | 2010 | 607 | 0.080 |
Why?
|
| New York | 2 | 2021 | 874 | 0.080 |
Why?
|
| Acoustic Stimulation | 1 | 2013 | 1235 | 0.080 |
Why?
|
| Saliva | 1 | 2013 | 828 | 0.080 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2011 | 240 | 0.080 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2012 | 1208 | 0.080 |
Why?
|
| Weight Gain | 1 | 2018 | 2348 | 0.080 |
Why?
|
| Personality | 1 | 2011 | 554 | 0.070 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 925 | 0.070 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 1436 | 0.070 |
Why?
|
| Alcohol Drinking | 2 | 2018 | 4028 | 0.070 |
Why?
|
| Tooth Loss | 1 | 2009 | 200 | 0.070 |
Why?
|
| Psychotic Disorders | 1 | 2022 | 3223 | 0.070 |
Why?
|
| Animals | 8 | 2024 | 168459 | 0.070 |
Why?
|
| Child Development | 1 | 2019 | 2306 | 0.070 |
Why?
|
| Enzymes | 1 | 2008 | 257 | 0.070 |
Why?
|
| Twin Studies as Topic | 1 | 2007 | 103 | 0.070 |
Why?
|
| Memory | 2 | 2016 | 2188 | 0.070 |
Why?
|
| Suicidal Ideation | 1 | 2016 | 1447 | 0.070 |
Why?
|
| Long QT Syndrome | 1 | 2011 | 467 | 0.070 |
Why?
|
| Methylation | 2 | 2019 | 1084 | 0.070 |
Why?
|
| Life Expectancy | 1 | 2013 | 1242 | 0.070 |
Why?
|
| Life Style | 3 | 2018 | 3917 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2010 | 3688 | 0.070 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2006 | 122 | 0.070 |
Why?
|
| Inositol | 1 | 2007 | 215 | 0.070 |
Why?
|
| Cerebellum | 1 | 2013 | 1501 | 0.060 |
Why?
|
| Specimen Handling | 1 | 2010 | 702 | 0.060 |
Why?
|
| Algorithms | 2 | 2019 | 14031 | 0.060 |
Why?
|
| Maternal Age | 2 | 2019 | 809 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2011 | 1007 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2017 | 4431 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2735 | 0.060 |
Why?
|
| Hydrocortisone | 1 | 2013 | 1819 | 0.060 |
Why?
|
| Educational Status | 1 | 2012 | 2522 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2019 | 6391 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 14666 | 0.060 |
Why?
|
| Inhalation Exposure | 2 | 2018 | 432 | 0.060 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 2897 | 0.060 |
Why?
|
| Choline | 1 | 2007 | 515 | 0.060 |
Why?
|
| Time | 1 | 2006 | 546 | 0.060 |
Why?
|
| Edema | 1 | 2009 | 766 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2013 | 7856 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 1666 | 0.060 |
Why?
|
| Creatinine | 1 | 2010 | 1899 | 0.060 |
Why?
|
| DNA Primers | 1 | 2008 | 2819 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2016 | 17904 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 15266 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2010 | 2281 | 0.060 |
Why?
|
| Respiratory Function Tests | 1 | 2008 | 1682 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2013 | 1936 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2007 | 960 | 0.050 |
Why?
|
| Spermatogenesis | 1 | 2024 | 259 | 0.050 |
Why?
|
| Pregnancy in Diabetics | 1 | 2024 | 197 | 0.050 |
Why?
|
| DNA | 1 | 2017 | 7212 | 0.050 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2009 | 1988 | 0.050 |
Why?
|
| Food | 1 | 2008 | 774 | 0.050 |
Why?
|
| Affect | 1 | 2010 | 1486 | 0.050 |
Why?
|
| Tetrazoles | 1 | 2009 | 909 | 0.050 |
Why?
|
| Hearing Loss | 1 | 2010 | 783 | 0.050 |
Why?
|
| Migraine Disorders | 1 | 2015 | 1701 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2013 | 2639 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 1999 | 5777 | 0.050 |
Why?
|
| Heat Exhaustion | 1 | 2002 | 13 | 0.050 |
Why?
|
| Psychological Tests | 1 | 2004 | 640 | 0.050 |
Why?
|
| Exercise | 2 | 2017 | 5890 | 0.050 |
Why?
|
| Nitrogen Oxides | 1 | 2022 | 129 | 0.050 |
Why?
|
| Ectoparasitic Infestations | 1 | 2001 | 11 | 0.050 |
Why?
|
| Heat Stroke | 1 | 2002 | 29 | 0.050 |
Why?
|
| Dracunculiasis | 1 | 2001 | 13 | 0.050 |
Why?
|
| Vitamin B 6 | 2 | 2014 | 234 | 0.050 |
Why?
|
| Diseases in Twins | 1 | 2004 | 446 | 0.050 |
Why?
|
| Onchocerca volvulus | 1 | 2001 | 15 | 0.050 |
Why?
|
| Arthralgia | 1 | 2006 | 461 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2017 | 6567 | 0.050 |
Why?
|
| Sex Factors | 6 | 2014 | 10552 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 2208 | 0.050 |
Why?
|
| Canada | 2 | 2019 | 2122 | 0.050 |
Why?
|
| Onchocerciasis | 1 | 2001 | 28 | 0.050 |
Why?
|
| Calcium | 1 | 2015 | 5722 | 0.050 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 847 | 0.050 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2024 | 339 | 0.050 |
Why?
|
| Sulfates | 1 | 2022 | 380 | 0.050 |
Why?
|
| Protons | 1 | 2007 | 1116 | 0.050 |
Why?
|
| Nitrates | 1 | 2022 | 263 | 0.050 |
Why?
|
| Stress, Psychological | 2 | 2022 | 4481 | 0.050 |
Why?
|
| Vitamin D | 1 | 2015 | 3303 | 0.050 |
Why?
|
| Poisson Distribution | 1 | 2002 | 504 | 0.050 |
Why?
|
| Bone Density | 1 | 2014 | 3551 | 0.050 |
Why?
|
| Indiana | 1 | 2020 | 92 | 0.040 |
Why?
|
| Hospitalization | 4 | 2022 | 10723 | 0.040 |
Why?
|
| Hospitals, Psychiatric | 1 | 2022 | 321 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2003 | 578 | 0.040 |
Why?
|
| Vitamin B 12 | 2 | 2014 | 524 | 0.040 |
Why?
|
| Loneliness | 1 | 2022 | 203 | 0.040 |
Why?
|
| Coffee | 1 | 2004 | 593 | 0.040 |
Why?
|
| Cell Count | 1 | 2004 | 1835 | 0.040 |
Why?
|
| Research | 1 | 2008 | 1982 | 0.040 |
Why?
|
| Problem Solving | 1 | 2022 | 441 | 0.040 |
Why?
|
| Molybdenum | 1 | 2019 | 46 | 0.040 |
Why?
|
| Public Health Practice | 1 | 2002 | 219 | 0.040 |
Why?
|
| Isoprostanes | 1 | 2019 | 19 | 0.040 |
Why?
|
| Cacodylic Acid | 1 | 2019 | 14 | 0.040 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2019 | 45 | 0.040 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1999 | 55 | 0.040 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2019 | 19 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2020 | 615 | 0.040 |
Why?
|
| Arthroscopy | 1 | 2006 | 969 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2009 | 2024 | 0.040 |
Why?
|
| Arthritis | 1 | 2024 | 680 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 547 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 1999 | 144 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2023 | 1080 | 0.040 |
Why?
|
| International Classification of Diseases | 1 | 2004 | 909 | 0.040 |
Why?
|
| N-Methylaspartate | 1 | 1999 | 231 | 0.040 |
Why?
|
| Thoracic Vertebrae | 1 | 2003 | 597 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 1039 | 0.040 |
Why?
|
| Tonometry, Ocular | 1 | 2019 | 235 | 0.040 |
Why?
|
| Benzene | 1 | 2018 | 106 | 0.040 |
Why?
|
| Geographic Information Systems | 1 | 2020 | 281 | 0.040 |
Why?
|
| Haplotypes | 2 | 2014 | 2713 | 0.040 |
Why?
|
| Hip Prosthesis | 1 | 2004 | 921 | 0.040 |
Why?
|
| Afferent Pathways | 1 | 1999 | 298 | 0.040 |
Why?
|
| Cotinine | 1 | 2018 | 206 | 0.040 |
Why?
|
| Estrogens | 1 | 2004 | 1522 | 0.040 |
Why?
|
| Vitamins | 2 | 2022 | 1635 | 0.040 |
Why?
|
| Hip Joint | 1 | 2004 | 1014 | 0.040 |
Why?
|
| Base Sequence | 1 | 2008 | 12441 | 0.040 |
Why?
|
| Half-Life | 1 | 2018 | 651 | 0.040 |
Why?
|
| Retirement | 1 | 2018 | 198 | 0.030 |
Why?
|
| Disaster Planning | 1 | 2003 | 557 | 0.030 |
Why?
|
| United States Environmental Protection Agency | 1 | 2017 | 139 | 0.030 |
Why?
|
| Cyclins | 1 | 2019 | 594 | 0.030 |
Why?
|
| Health Personnel | 2 | 2016 | 3335 | 0.030 |
Why?
|
| Fetus | 1 | 2024 | 1863 | 0.030 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1999 | 448 | 0.030 |
Why?
|
| Acceleration | 1 | 2017 | 189 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 1999 | 927 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 2019 | 327 | 0.030 |
Why?
|
| Recovery of Function | 2 | 2004 | 2979 | 0.030 |
Why?
|
| Methyltransferases | 1 | 2019 | 377 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 2078 | 0.030 |
Why?
|
| C-Reactive Protein | 2 | 2019 | 3826 | 0.030 |
Why?
|
| Urban Population | 1 | 2024 | 2036 | 0.030 |
Why?
|
| Osteoarthritis, Knee | 1 | 2006 | 1234 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1999 | 1090 | 0.030 |
Why?
|
| Vitis | 1 | 2015 | 19 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2019 | 907 | 0.030 |
Why?
|
| Potassium | 1 | 2019 | 1311 | 0.030 |
Why?
|
| Menstrual Cycle | 1 | 2019 | 539 | 0.030 |
Why?
|
| Temperature | 1 | 2022 | 2226 | 0.030 |
Why?
|
| Zinc | 1 | 2019 | 690 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2023 | 1755 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2021 | 7967 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2019 | 763 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2022 | 1808 | 0.030 |
Why?
|
| Sodium | 1 | 2019 | 1588 | 0.030 |
Why?
|
| Medicare | 2 | 2023 | 6770 | 0.030 |
Why?
|
| Universities | 1 | 2019 | 993 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2015 | 224 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 1999 | 1736 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 18252 | 0.030 |
Why?
|
| Intelligence | 1 | 2019 | 924 | 0.030 |
Why?
|
| Reoperation | 1 | 2004 | 4303 | 0.030 |
Why?
|
| Brain | 3 | 2023 | 27112 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2006 | 2781 | 0.030 |
Why?
|
| Genes, Protozoan | 1 | 2013 | 170 | 0.030 |
Why?
|
| Vegetables | 1 | 2018 | 1195 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2003 | 3550 | 0.030 |
Why?
|
| Indonesia | 1 | 2012 | 128 | 0.030 |
Why?
|
| tau Proteins | 1 | 2023 | 2095 | 0.030 |
Why?
|
| Internet | 2 | 2016 | 3092 | 0.030 |
Why?
|
| Thalamus | 1 | 1999 | 1045 | 0.030 |
Why?
|
| Empirical Research | 1 | 2012 | 120 | 0.030 |
Why?
|
| CpG Islands | 1 | 2017 | 1230 | 0.020 |
Why?
|
| New England | 1 | 2015 | 1054 | 0.020 |
Why?
|
| Inflammation | 1 | 2011 | 10773 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2019 | 1139 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2016 | 771 | 0.020 |
Why?
|
| Bacteria | 1 | 2022 | 2199 | 0.020 |
Why?
|
| Industrial Waste | 1 | 2010 | 23 | 0.020 |
Why?
|
| West Virginia | 1 | 2010 | 31 | 0.020 |
Why?
|
| Energy Intake | 1 | 2018 | 2134 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2019 | 1958 | 0.020 |
Why?
|
| Chemical Industry | 1 | 2010 | 116 | 0.020 |
Why?
|
| Developed Countries | 1 | 2013 | 449 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2010 | 69 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 29625 | 0.020 |
Why?
|
| Ohio | 1 | 2010 | 322 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 3839 | 0.020 |
Why?
|
| Random Allocation | 1 | 2014 | 2395 | 0.020 |
Why?
|
| Peru | 1 | 2012 | 891 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2011 | 650 | 0.020 |
Why?
|
| Length of Stay | 1 | 2003 | 6425 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 1250 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3882 | 0.020 |
Why?
|
| Data Collection | 1 | 2018 | 3322 | 0.020 |
Why?
|
| Genome | 1 | 2017 | 1740 | 0.020 |
Why?
|
| Tanzania | 1 | 2012 | 1387 | 0.020 |
Why?
|
| Morbidity | 1 | 2013 | 1750 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 4671 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 8181 | 0.020 |
Why?
|
| Protozoan Proteins | 1 | 2013 | 847 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 6485 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2008 | 376 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 11903 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2009 | 64680 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2009 | 616 | 0.020 |
Why?
|
| Skin | 1 | 2019 | 4484 | 0.020 |
Why?
|
| Dietary Supplements | 2 | 2011 | 3415 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2013 | 2932 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2010 | 751 | 0.010 |
Why?
|
| Neurons | 1 | 2004 | 9463 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2006 | 363 | 0.010 |
Why?
|
| Diet Surveys | 1 | 2008 | 1162 | 0.010 |
Why?
|
| Triglycerides | 1 | 2011 | 2461 | 0.010 |
Why?
|
| Disabled Persons | 1 | 2013 | 1225 | 0.010 |
Why?
|
| Debridement | 1 | 2006 | 494 | 0.010 |
Why?
|
| Polymers | 1 | 2010 | 1617 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8654 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2009 | 2048 | 0.010 |
Why?
|
| Rats | 1 | 1999 | 23742 | 0.010 |
Why?
|
| Placebo Effect | 1 | 2006 | 518 | 0.010 |
Why?
|
| Parity | 1 | 2004 | 927 | 0.010 |
Why?
|
| Titanium | 1 | 2004 | 485 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6075 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2004 | 1416 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 7594 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2006 | 1347 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4358 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 4853 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2010 | 5079 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10766 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2006 | 12341 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 23445 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 8002 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2001 | 12974 | 0.000 |
Why?
|